How fructose drives non-alcoholic fatty liver disease.
What the evidence says
- *NAFLD is estimated to affect about 1 billion people worldwide* — `csf05`'s own figure — and is the most common cause of elevated liver enzymes and the third most common indication for liver transplantation[1]
- Fructose is primarily metabolized in the liver — liver extracts 50-70% of delivered fructose on first pass[1],[2]
- Fructose bypasses key regulatory step (phosphofructokinase), rapidly converting to fat[1]
- High fructose intake overwhelms liver's metabolic capacity[1]
- Replacing complex carbohydrates with fructose raised liver fat to *137% of control (Q1 116%, Q3 183%; P = .016) within 9 days at neutral energy balance and no weight change — in 7 men, of 8 enrolled, all healthy inpatients. The absolute values are small: median 1.02% on fructose against 0.70% on control, both far below the ~5% steatosis threshold, and liver fat above 5% was an exclusion criterion. The authors' own word for the result is "modestly higher"*[3]
- Fructose consumption increased from ~15g/day to ~55g/day over past century[1]
- Fructose metabolism parallels ethanol metabolism in the liver[4]
- Both fructose and ethanol can cause steatohepatitis and dyslipidemia[4]
- NAFLD follows a "two-hit" model: first hit is lipid accumulation (DNL, β-oxidation inhibition); second hit is inflammation from protein fructosylation (Maillard reaction) and reactive oxygen species[4]
- Fructose does not stimulate insulin or leptin release (no satiety signal)[4]
- Ketohexokinase knockdown improved hepatic steatosis (liver triglycerides decreased 30-35%) and glucose tolerance in fructose-fed mice[5]
- Lipogenic enzymes (ACLY, ACACA, FASN, SCD1) increased 2-10 fold in human adolescents with NASH vs no fatty liver[5]
- Liver lipid composition, rather than overall amount, is linked with progressive liver disease — fructose produces both microvesicular and macrovesicular steatosis[5]
- De novo lipogenesis contributes 26% of accumulated hepatic triglycerides in NAFLD patients vs less than 5% in healthy subjects; separately, DNL contributes 23% of liver fat in NAFLD vs 10% in controls, while dietary fat contribution is identical (5%) in both groups[2],[1]
- Selective insulin resistance in NAFLD: insulin continues promoting DNL while failing to suppress hepatic gluconeogenesis[1]
- Fructose provokes hepatic stress response via JNK activation, which reduces hepatic insulin signaling — creating a vicious cycle where fatty liver worsens insulin resistance[2]
- Fast-food diets combining fructose and fat produce hepatic fibrosis, inflammation, and ER stress; high-fat diets alone produce only minimal inflammation and no fibrosis[2]
- Within added sugars, the fructose component (not the glucose component) is the primary driver of NAFLD/NASH[6]
- Reducing sugary-beverage and total added-fructose intake may significantly reduce hepatic fat accumulation — a modifiable, liver-protective dietary change[6]